Type 1 diabetes confers a cardiovascular burden that is often obscured by the young age of affected individuals and by the ...

Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...

The benefit of fractional flow reserve (FFR)–guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains ...

PARIS, France—Among patients with acute MI and occlusive disease on invasive angiography, those presenting without ST-segment elevation on the initial ECG fare worse than those with STEMI, researchers ...

In a recent study published in The Lancet Regional Health - Europe, a group of researchers identified subpopulations at heightened risk for ST-elevation myocardial infarction (STEMI) and ...

Some clinicians say that testing for occlusion myocardial infarction (OMI) instead might be a better tool for making that determination. “We think we should get rid of the term ST-elevation MI, ...

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...

myocardial infarction, heart attack Even patients with advanced CKD or receiving dialysis appear to benefit from guideline-directed STEMI therapies, according to a retrospective study. Patients with ...

WASHINGTON, DC – OCTOBER 29, 2024 – The largest trial to examine the impact of colchicine in acute myocardial infarction (MI) found that both acute and long-term colchicine use did not reduce ...

Freeman Heart & Vascular Institute has earned Level 1 STEMI designation from the Missouri Department of Health and Senior ...